Delayed reinforcement of costimulation improves the efficacy of mRNA vaccines in mice
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci183973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Sarah Sanchez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology-Immunology, and. Hauptthemen laut MEDLINE: mRNA Vaccines, Immunogenicity, Vaccine, Tumor Necrosis Factor Receptor Superfamily, Member 9, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIAID NIH HHS, NIH.
Abstract (Originalsprache)
mRNA vaccines have demonstrated efficacy during the COVID-19 pandemic and are now being investigated for multiple diseases. However, concerns linger about the durability of immune responses, and the high incidence of breakthrough infections among vaccinated individuals highlights the need for improved mRNA vaccines. In this study, we investigated the effects of reinforcing costimulation via 4-1BB, a member of the TNF receptor superfamily, on immune responses elicited by mRNA vaccines. We first immunized mice with mRNA vaccines, followed by treatment with 4-1BB costimulatory antibodies to reinforce the 4-1BB pathway at different time points after vaccination. Consistent with prior studies, reinforcing 4-1BB costimulation on the day of vaccination did not result in a substantial improvement in vaccine responses. However, reinforcing 4-1BB costimulation on day 4 after vaccination, when 4-1BB expression levels were highest, resulted in a profound improvement in CD8+ T cell responses associated with enhanced protection against pathogen challenges. A similar clinical benefit was observed in a therapeutic cancer vaccine model. We also report time-dependent effects with OX40, another costimulatory molecule of the TNF receptor superfamily. These findings demonstrate that delayed reinforcement of costimulation may exert an immunologic benefit, providing insights for the development of more effective mRNA vaccines for infectious diseases and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology-Immunology, and.
- Department of Medicine, Division of Allergy and Immunology, Feinberg School of Medicine and Center for Human Immunobiology, Northwestern University, Chicago, Illinois, USA.
Förderung
- NIDA NIH HHS
- NIAID NIH HHS
- NIH
- NIAID
- Third Coast CFAR
Zitieren
APA
Sanchez, S., Dangi, T., Awakoaiye, B., Lew, M. H., Irani, N., Fourati, S., & Penaloza-MacMaster, P. (2024). Delayed reinforcement of costimulation improves the efficacy of mRNA vaccines in mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci183973
Vancouver
Sanchez S, Dangi T, Awakoaiye B, Lew MH, Irani N, Fourati S, et al. Delayed reinforcement of costimulation improves the efficacy of mRNA vaccines in mice. Journal of Clinical Investigation. 2024. doi:10.1172/jci183973
BibTeX
@article{Sanchez2024,
author = {Sanchez, Sarah and Dangi, Tanushree and Awakoaiye, Bakare and Lew, Min Han and Irani, Nahid and Fourati, Slim and Penaloza-MacMaster, Pablo},
title = {Delayed reinforcement of costimulation improves the efficacy of mRNA vaccines in mice},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci183973}
}
EUVIMED